Cognitive and behavioral impact of antiseizure medications, neuromodulation, ketogenic diet, and surgery in lennox-gastaut syndrome: A comprehensive review
Epilepsy & Behavior,
Journal Year:
2025,
Volume and Issue:
164, P. 110272 - 110272
Published: Jan. 23, 2025
Language: Английский
Patient-advocate-led global coalition adapting fit-for-purpose outcomes measures to assure meaningful inclusion of DEEs in clinical trials
Therapeutic Advances in Rare Disease,
Journal Year:
2024,
Volume and Issue:
5
Published: Jan. 1, 2024
Existing
clinical
tools
that
measure
non-seizure
outcomes
lack
the
range
and
granularity
needed
to
capture
skills
in
developmental
epileptic
encephalopathy
(DEE)-affected
individuals
who
also
fall
severe
profound
of
intellectual
disability.
This
effectively
excludes
those
with
impairments
from
trials,
impeding
ability
sponsors
evaluate
disease-modifying
therapies
(DMTs).
The
Inchstone
Project,
an
international,
patient
advocate-led
collaboration,
brings
together
leading
researchers,
clinicians,
pharmaceutical
companies,
advocates
develop
adapted,
validated
assessment
battery
within
5
years.
goal
is
support
trials
DMTs
for
DEEs
by
providing
sufficiently
sensitive
measurement
demonstrate
therapeutic
efficacy.
An
initial
pilot
study
administered
7
established
assessments
10
affected
SCN2A-DEE,
identifying
specific
limitations
existing
measures
areas
improvement.
It
was
clear
most
do
not
account
challenges
throughout
DEE
population,
including
vision
impairments,
significant
motor
disability,
which
need
be
accounted
creating
a
'fit-for-purpose'
population.
Several
novel
assessments,
two
responsivity
developed
use
monitoring
recovery
after
acquired
brain
injury
as
well
individualized
Goal
Attainment
Scaling,
showed
promise
this
group.
team
completed
DEE-wide
survey
over
270
caregivers
documenting
their
children's
abilities
priorities
improvement
new
treatments.
using
information
how
might
updated
better
what
important
families
child's
small
but
improvements
time.
These
efforts
are
building
coherent
picture
across
multiple
domains,
or
concepts
interest,
have
greatest
impact
on
patients
families.
course
adapt
outcome
(1)
increments
meaningful
change
('Inchstones')
(2)
applicable
conditions.
Language: Английский
Characterizing executive functioning and associated behaviors in individuals with dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) syndrome
Frontiers in Neuroscience,
Journal Year:
2025,
Volume and Issue:
18
Published: Jan. 7, 2025
DYRK1A,
a
protein
kinase
located
on
human
chromosome
21,
plays
role
in
postembryonic
neuronal
development
and
degeneration.
Alterations
to
DYRK1A
have
been
consistently
associated
with
cognitive
functioning
neurodevelopmental
disorders
(e.g.,
autism,
intellectual
disability).
However,
the
broader
behavioral
phenotype
of
syndrome
requires
further
characterization.
Specifically,
executive
functioning,
or
processes
that
are
necessary
for
goal-directed
behavior,
has
not
yet
characterized
this
population.
Individuals
variants
(n
=
29;
ages
4
21
years)
were
assessed
standardized
protocol
multiple
measures
functioning:
Delis-Kaplan
Executive
Function
Schedule,
chronologically
age-appropriate
caregiver-report
forms
Behavior
Rating
Inventory
(BRIEF)
Achenbach
System
Empirically
Based
Assessment
(ASEBA).
We
first
examined
feasibility
appropriateness
established
among
participants
inform
selection
tools
future
research.
then
group,
including
associations
other
phenotypic
features.
Neurocognitive
assessments
deemed
infeasible
due
verbal
functioning.
Caregiver-report
revealed
elevated
concerns
related
self-monitoring,
working
memory,
planning/organization
BRIEF,
attention
ADHD
CBCL.
Only
two
had
existing
diagnoses;
however,
5
(out
10
data)
exceeded
cutoff
13
individuals
27
ASEBA
subscale,
18
subscale.
There
was
concordance
between
diagnosis
ASEBA,
but
BRIEF.
correlated
nonverbal
IQ
autism
traits.
Objective
needed
disability
who
and/or
motor
limitations.
Diagnostic
overshadowing,
tendency
attribute
all
problems
leave
co-existing
conditions,
such
as
challenges
ADHD,
undiagnosed,
is
common.
Phenotypic
characterization
therefore
important
our
understanding
ensuring
caregivers'
addressed,
receive
clinical
services
best
meet
their
needs.
Language: Английский
Vineland-3 Growth Scale Values: Psychometric Properties for Clinical Trial Readiness in SCN2A
Journal of Child and Adolescent Psychopharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 31, 2025
Purpose:
The
Vineland
Adaptive
Behavior
Scales-3rd
Edition
(Vineland-3)
is
one
of
the
most
used
measures
adaptive
behavior
among
those
with
sodium
channel
protein
type
2
subunit
alpha
related
disorders
(SCN2A-RDs).
Several
disease-modifying
treatments
are
in
early
trials
for
SCN2A-RDs,
and
as
such,
clinical
outcome
assessments
(COAs)
necessary.
Vineland-3
introduced
growth
scale
values
(GSVs),
which
useful
measuring
within-person
change
thus
may
be
future
trials.
purpose
this
study
was
to
evaluate
psychometric
properties
GSVs
SCN2A-RDs
preparation
Methods:
A
sample
65
individuals
(mean
=
108,
SD
76.0
months)
recruited
a
trial
readiness
study.
Comprehensive
Interview
administered
by
trained
raters
at
regular
intervals.
Multiple
were
evaluated,
including
floor
ceiling
effects,
split-half
internal
consistency,
test-retest
reliability,
inter-rater
reliability
(on
approximately
20%
all
completions).
Results:
Floor
effects
relatively
infrequent
on
GSV
metric
but
occurred
subdomains
using
norm-referenced
v-scale
metric.
Split-half
excellent
(rxx
>0.95
inter-class
correlation
coefficient
[ICC]
>0.90,
respectively),
except
coping,
still
maintained
adequate
0.87,
ICC
0.65).
Inter-rater
also
very
strong,
though
it
more
variable
(αkripp
range
0.78-1.00).
Conclusion:
holds
great
potential
COA
SCN2A-RDs;
exhibited
strong
sample.
This
prerequisite
level
evidence
needed
demonstrate
that
measure
fit-for-purpose
While
some
high,
domains
(e.g.,
domestic)
problems
suggest
they
less
relevant
population.
Future
studies
should
expand
mixed-methods
research
prioritizing
concepts
interest
Vineland-3.
Language: Английский
Caregiver‐reported meaningful change in functional domains for individuals with developmental and epileptic encephalopathy: A convergent mixed‐methods design
Developmental Medicine & Child Neurology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 15, 2025
Abstract
Aim
To
investigate
how
caregivers
of
children
with
developmental
and
epileptic
encephalopathy
severe
impairments
describe
meaningful
change
for
functional
domains
why
it
is
important.
Method
This
was
a
convergent
mixed‐methods
design
study.
A
survey
completed
by
267
parents
aged
12
months
or
older.
For
prioritized
(communication,
gross
motor,
fine
eating),
reported
the
smallest
improvement
that
would
be
important
explained
why.
Data
were
analyzed
using
directed
content
analysis
codes
mapped
to
impairment
levels.
Results
The
median
age
8
years
(interquartile
range
4
2
months–14
6
months)
149
(55.8%)
female.
Content
yielded
86
codes.
Common
described
capacity
communicate
preferences
emotions,
gain
sitting
walking
skills,
grasp
objects
play,
eat
foods
without
choking,
utensils.
Some
each
level
(e.g.
communicating
needs/wants/likes
expressive
communication);
others
specific
an
gaining
head
control
if
unable
walk).
Meaningful
anticipated
affect
health,
independence
safety,
care
regimens,
quality
life
affected
individual
families.
Interpretation
indicate
critical
components
within
evaluations
in
clinical
trials.
Language: Английский
Family and Caregiver Perspectives on Gene Therapy for Rett Syndrome
Keri Ramsey,
No information about this author
Madison LaFleur,
No information about this author
Kiana Robinson
No information about this author
et al.
Rare,
Journal Year:
2024,
Volume and Issue:
2, P. 100045 - 100045
Published: Jan. 1, 2024
Language: Английский
Assessing Communication Impairments in a Rare Neurodevelopmental Disorder
Neurology Clinical Practice,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Oct. 18, 2024
-related
disorders
(
Language: Английский
International workshop: what is needed to ensure outcome measures for Rett syndrome are fit-for-purpose for clinical trials? June 7, 2023, Nashville, USA
Trials,
Journal Year:
2024,
Volume and Issue:
25(1)
Published: Dec. 21, 2024
Language: Английский
Rest-Activity Rhythm Phenotypes in Adults with Epilepsy and Intellectual Disability
Nandani Adhyapak,
No information about this author
Grace E Cardenas,
No information about this author
Mark A Abboud
No information about this author
et al.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 10, 2024
Sleep
and
rest-activity
rhythms
(RARs)
are
perturbed
in
many
forms
of
neuropsychiatric
illness.
In
this
study,
we
applied
wrist
actigraphy
to
describe
the
extent
RAR
perturbations
adults
with
epilepsy
intellectual
disability
("E+ID"),
using
a
cross-sectional
case-control
design.
We
examined
whether
phenotypes
correlated
severity,
deficits
adaptive
function
and/or
comorbid
psychopathology.
Language: Английский